01 1Combivir
02 5Dovato
03 2Epzicom/Kivexa
04 5Triumeq
05 5Zeffix
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 3,197
2019 Revenue in Millions : 3,534
Growth (%) : -10
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 43
2019 Revenue in Millions : 104
Growth (%) : -59
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 518
2019 Revenue in Millions : 78
Growth (%) : 568
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 1,065
2020 Revenue in Millions : 512
Growth (%) : 110
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 2,547
2020 Revenue in Millions : 3,159
Growth (%) : -18
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 2,218
2021 Revenue in Millions : 2,547
Growth (%) : -13
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 1,695
2021 Revenue in Millions : 1,065
Growth (%) : 59
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 1,664
2022 Revenue in Millions : 2,218
Growth (%) : -14
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 1,963
2022 Revenue in Millions : 1,695
Growth (%) : 32
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 236
2014 Revenue in Millions : 190
Growth (%) : -19%
LOOKING FOR A SUPPLIER?